An Investigation into quality assurance of the Open Source Software Development model

A thesis submitted in partial fulfilment of the requirements of the University of Wolverhampton for the degree of Doctor of PhilosophyThe Open Source Software Development (OSSD) model has launched products in rapid succession and with high quality, without following traditional quality practices of accepted software development models (Raymond 1999). Some OSSD projects challenge established quality assurance approaches, claiming to be successful through partial contrary techniques of standard software development. However, empirical studies of quality assurance practices for Open Source Software (OSS) are rare (Glass 2001). Therefore, further research is required to evaluate the quality assurance processes and methods within the OSSD model. The aim of this research is to improve the understanding of quality assurance practices under the OSSD model. The OSSD model is characterised by a collaborative, distributed development approach with public communication, free participation, free entry to the project for newcomers and unlimited access to the source code. The research examines applied quality assurance practices from a process view rather than from a product view. The research follows ideographic and nomothetic methodologies and adopts an antipositivist epistemological approach. An empirical research of applied quality assurance practices in OSS projects is conducted through the literature research. The survey research method is used to gain empirical evidence about applied practices. The findings are used to validate the theoretical knowledge and to obtain further expertise about practical approaches. The findings contribute to the development of a quality assurance framework for standard OSSD approaches. The result is an appropriate quality model with metrics that the requirements of the OSSD support. An ideographic approach with case studies is used to extend the body of knowledge and to assess the feasibility and applicability of the quality assurance framework. In conclusion, the study provides further understanding of the applied quality assurance processes under the OSSD model and shows how a quality assurance framework can support the development processes with guidelines and measurements

Land Cover Changes (1963–2010) and Their Environmental Factors in the Upper Danube Floodplain

To analyze the changes in the Upper Danube Floodplain, we used aerial photos to quantify the change of landscape pattern from 1963 to 2010. We focused on typical floodplain habitats, i.e., riparian forest and floodplain grassland. We used landscape metrics and transformation matrix to explore changes in land cover structure and composition. The active floodplain experienced increasing fragmentation from 1963 to 2010. Despite an increase of aggregation, riparian forest suffered a 2.3% area loss from 1995 to 2010. Arable land in the active floodplain declined by 28.5%, while its patch size significantly increased. Elevation, distance to river and soil quality were the most relevant environmental factors for the land cover change in the floodplain. Higher soil quality or longer distance to river led to an increase of conversion from grassland into arable land; grassland patches with poorer soil quality were likely to change into riparian forest; riparian forest closer to the river and with a lower height above mean water level tended to remain stable. This comprehensive understanding of historical land cover change and environmental factors is needed for the enhancement of landscape functions and sustainable development in the floodplain

Analysis of production bottlenecks in BiTE® molecules producing CHO cells

Please click Additional Files below to see the full abstract

Immunological substrates of depressive symptoms in patients with severe obesity: An exploratory study

In this pilot study, we explored the immune phenotype of patients with severe obesity and comorbid depressive symptoms compared to non-depressed patients with obesity and normal-weight controls. Immune cell subsets were analysed by flow cytometry and depressive symptoms assessed using the Patient Health Questionnaire (PHQ-9). Cell frequencies were correlated with depressive symptom scores and waist-to-hip ratio (WHR). Patients with obesity and comorbid depression showed significantly lower numbers of circulating cytotoxic natural killer cells, dendritic cells and CD8(+) effector memory T cells, compared to normal-weight controls. Regulatory T cells and CD4(+) central memory T cells were increased compared to non-depressed patients with obesity and compared to normal-weight controls, respectively. Frequencies of cytotoxic natural killer cells and CD4(+) central memory T cells significantly correlated with PHQ-9 scores, but not with WHR. Reduced numbers of dendritic cells were observed in both patient groups with obesity and correlated with PHQ-9 scores and WHR. These findings provide evidence for an altered immune composition in comorbid obesity and depression, supporting a pathobiological overlap between the two disorders

Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery

<p>Abstract</p> <p>Background</p> <p>Adenoviral vectors have provided effective methods for <it>in vivo </it>gene delivery in therapeutic applications. However, these vectors can induce immune responses that may severely affect the ability of vector re-application. There is limited information about the mechanisms and signal transduction pathways involved in adenoviral recognition. For optimization of cutaneous gene therapy it is necessary to investigate molecular mechanisms of virus recognition in epidermal cells. The aim of this study was to investigate the signal transduction of the innate immunity after adenoviral DNA internalization in keratinocytes.</p> <p>Methods</p> <p><it>In vitro</it>, keratinocytes were transfected with DNA, in the presence and absence of inhibitors for signalling molecules. <it>In vivo</it>, immunocompetent and athymic mice (n = 3 per group) were twice transduced with an Ad-vector.</p> <p>Results</p> <p>The results show an acute induction of type-I-interferon after <it>in vitro </it>transfection. Inhibition of PI3K, p38 MAPK, JNK and NFkappaB resulted in a decreased expression of type-I-interferon. In contrast to immunocompetent mice, athymic mice demonstrated a constant transgene expression and reduced inflammatory response <it>in vivo</it>.</p> <p>Conclusion</p> <p>The results suggest an induction of the innate immunity triggered by cytoplasm localised DNA which is mediated by PI3K-, p38 MAPK-, JNK-, NFkappaB-, JAK/STAT- and ERK1/2-dependent pathways. A stable transgene expression and a reduced inflammatory response in immunodeficient mice have been observed. These results provide potential for an effective adenoviral gene delivery into immunosupressed skin.</p

Instrumental Assessment of Stepping in Place Captures Clinically Relevant Motor Symptoms of Parkinson’s Disease

Fluctuations of motor symptoms make clinical assessment in Parkinson's disease a complex task. New technologies aim to quantify motor symptoms, and their remote application holds potential for a closer monitoring of treatment effects. The focus of this study was to explore the potential of a stepping in place task using RGB-Depth (RGBD) camera technology to assess motor symptoms of people with Parkinson's disease. In total, 25 persons performed a 40 s stepping in place task in front of a single RGBD camera (Kinect for Xbox One) in up to two different therapeutic states. Eight kinematic parameters were derived from knee movements to describe features of hypokinesia, asymmetry, and arrhythmicity of stepping. To explore their potential clinical utility, these parameters were analyzed for their Spearman's Rho rank correlation to clinical ratings, and for intraindividual changes between treatment conditions using standard response mean and paired t-test. Test performance not only differed between ON and OFF treatment conditions, but showed moderate correlations to clinical ratings, specifically ratings of postural instability (pull test). Furthermore, the test elicited freezing in some subjects. Results suggest that this single standardized motor task is a promising candidate to assess an array of relevant motor symptoms of Parkinson's disease. The simple technical test setup would allow future use by patients themselves

Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial

Introduction: Major depressive disorder (MDD) and obesity are both common disorders associated with significant burden of disease worldwide. Importantly, MDD and obesity often co-occur, with each disorder increasing the risk for developing the other by about 50%-60%. Statins are among the most prescribed medications with well-established safety and efficacy. Statins are recommended in primary prevention of cardiovascular disease, which has been linked to both MDD and obesity. Moreover, statins are promising candidates to treat MDD because a meta-analysis of pilot randomised controlled trials has found antidepressive effects of statins as adjunct therapy to antidepressants. However, no study so far has tested the antidepressive potential of statins in patients with MDD and comorbid obesity. Importantly, this is a difficult-to-treat population that often exhibits a chronic course of MDD and is more likely to be treatment resistant. Thus, in this confirmatory randomised controlled trial, we will determine whether add-on simvastatin to standard antidepressant medication with escitalopram is more efficacious than add-on placebo over 12 weeks in 160 patients with MDD and comorbid obesity. Methods and analysis: This is a protocol for a randomised, placebo-controlled, double-blind multicentre trial with parallel-group design (phase II). One hundred and sixty patients with MDD and comorbid obesity will be randomised 1:1 to simvastatin or placebo as add-on to standard antidepressant medication with escitalopram. The primary outcome is change in the Montgomery-angstrom sberg Depression Rating Scale (MADRS) score from baseline to week 12. Secondary outcomes include MADRS response (defined as 50% MADRS score reduction from baseline), MADRS remission (defined as MADRS score <10), mean change in patients' self-reported Beck Depression Inventory (BDI-II) and mean change in high-density lipoprotein, low-density lipoprotein and total cholesterol from baseline to week 12. Ethics and dissemination: This protocol has been approved by the ethics committee of the federal state of Berlin (Ethik-Kommission des Landes Berlin, reference: 19/0226-EK 11) and by the relevant federal authority (Bundesinstitut fur Arzneimittel und Medizinprodukte (BfArM), reference: 4043387). Study findings will be published in peer-reviewed journals and will be presented at (inter)national conferences

FUmanoid team description 2009

Abstract. This document describes hardware and software of the robots developed by the &quot;FUmanoid&quot; Team for the RoboCup competitions to be held in Graz, Austria 2009. The robot has 22 actuated degrees of freedom based on Dynamixel RX28, and RX64 servos. Central Processing, including Machine vision, Planning and control is performed using a Gumstix Verdex 6LP which is an ARM based 600MHz platform. Planning algorithms are organized in a new structure called Concurrent Scenario based Planning (CSBP). This paper explains the software and hardware used for the robot as well as control and stabilization methods developed by our team